BHCM
RVMD icon

Brevan Howard Capital Management’s Revolution Medicines RVMD Stock Holding History

Brevan Howard Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$914K Sell
4,883
-11,622
-70% -$1.7M 0.01% 1112
2026
Q1 		$1.61M Sell
16,505
-16,302
-50% -$1.65M 0.01% 662
2025
Q4 		$2.61M Buy
32,807
+1,644
+5% +$108K 0.03% 396
2025
Q3 		$1.46M Sell
31,163
-172,957
-85% -$6.77M 0.01% 721
2025
Q2 		$7.51M Buy
+204,120
New +$7.84M 0.04% 248
2025
Q1 		– Sell
-41,884
Closed -$1.83M – 1417
2024
Q4 		$1.83M Buy
41,884
+30,796
+278% +$1.55M 0.01% 303
2024
Q3 		$503K Sell
11,088
-3,613
-25% -$157K ﹤0.01% 677
2024
Q2 		$571K Sell
14,701
-4,235
-22% -$158K 0.01% 556
2024
Q1 		$610K Buy
+18,936
New +$561K 0.01% 396

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Brevan Howard Capital Management's RVMD Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Revolution Medicines (RVMD) stake by 70% in Q2 2026, selling an estimated $1.7M and leaving 4,883 shares worth $914K. The position accounts for 0.01% of the portfolio, ranked #1112.

Brevan Howard Capital Management first reported a position in RVMD in Q1 2024 and has held it in 9 quarters since. The position peaked at $7.51M in Q2 2025. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Brevan Howard Capital Management held 4,883 shares of Revolution Medicines worth $914K as of Q2 2026.
  • Brevan Howard Capital Management sold 11,622 Revolution Medicines shares in Q2 2026, an estimated $1.7M.
  • Revolution Medicines made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1112 holding.
  • Brevan Howard Capital Management first reported a position in Revolution Medicines in Q1 2024 and has held it in 9 quarters since.
  • Brevan Howard Capital Management's Revolution Medicines position peaked at $7.51M in Q2 2025.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.